Toshiaki Ochiai

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Katsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 80 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +12

Hair analysis for drugs of abuse

Yuji Nakahara, Toshiaki Ochiai, Ruri Kikura · Archives of Toxicology · 1992 · 76 citations

Pharmacy, Toxicology, Forensic Toxicology +10

Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification

Kazuhiko Nakamura, Mikako Osada, Ayako Goto et al. · Scandinavian Journal of Gastroenterology · 2015 · 42 citations

Medicine, Oncology, Surgery +17

Suitability of the expanded indication criteria for the treatment of early gastric cancer by endoscopic submucosal dissection: Japanese multicenter large-scale retrospective analysis of short- and long-term outcomes

Kazuhiko Nakamura, Kuniomi Honda, Kazuya Akahoshi et al. · Scandinavian Journal of Gastroenterology · 2015 · 34 citations

Medicine, Oncology, Surgery +17